Skip to main content
Retour
Watch Compare

20/20 Biolabs, Inc.

Qualité des données : 100%
AIDX
Nasdaq Services Engineering & Management Services
1,88 €
▲ 0,04 € (2,17%)
Cap. Boursière: 19,84 M
Prix
1,90 €
Cap. Boursière
19,84 M
Fourchette du Jour
—
Fourchette 52 Semaines
—
Volume
—
Ouverture —
Moyenne 50J / 200J
—
Moyenne 50J / 200J
—

Quick Summary

Points Clés

Negative free cash flow of -1,92 M

Croissance

Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A

Qualité

Return on Equity
N/A
ROIC-157,17%
Net Margin-182,82%
Op. Margin-162,87%

Sécurité

Debt / Equity
N/A
Current Ratio0,60
Interest Coverage-21,32

Valorisation

PE (TTM)
-5,31
En dessous de la moyenne du secteur (-1,17)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

Historique des Prix

Tendances Financières

Comparaison Sectorielle

vs médiane du secteur Services (502 pairs)
Métrique Action Médiane du Secteur
P/E -5,3 -1,2
P/B — 1,4
ROE % — -16,0
Net Margin % -182,8 -18,3
Rev Growth 5Y % — 4,2
D/E — 0,4

Objectif de Cours des Analystes

Aucune couverture d'analyste disponible

Estimations de Bénéfices

Aucune estimation prévisionnelle disponible

All Fundamental Metrics
Growth
Revenue Growth (1Y) N/A Revenue Growth (3Y) N/A
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 2,05 M Net Income (TTM) -3,74 M
ROE N/A ROA -90,37%
Gross Margin 29,56% Operating Margin -162,87%
Net Margin -182,82% Free Cash Flow (TTM) -1,92 M
ROIC -157,17% FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0,60
Interest Coverage -21,32 Asset Turnover 0,49
Working Capital -992 008 Tangible Book Value -221 489
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -5,31 Forward P/E N/A
P/B Ratio N/A P/S Ratio 9,70
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -9,68%
Market Cap 19,84 M Enterprise Value 18,82 M
Per Share
EPS (Diluted TTM) -0,76 Revenue / Share 0,20
FCF / Share -0,18 OCF / Share -0,18
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 51,35%
SBC-Adj. FCF -2,44 M Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2025
Revenue 2,05 M
Net Income -3,74 M
EPS (Diluted) -0,76
Gross Profit 604 541,0
Operating Income -3,33 M
EBITDA —
R&D Expenses 592 569,0
SG&A Expenses 3,34 M
D&A 63 257,0
Interest Expense 156 207,0
Income Tax —

Balance Sheet

Annual, most recent first
Metric FY2025
Total Assets 4,14 M
Total Liabilities 4,16 M
Shareholders' Equity -19 225,0
Total Debt —
Cash & Equivalents 1,03 M
Current Assets 1,47 M
Current Liabilities 2,46 M